JAZZ NASDAQ
Jazz Pharmaceuticals plc
1W: -3.3%
1M: -13.2%
3M: -19.2%
YTD: +19.4%
1Y: +49.3%
3Y: +54.8%
5Y: +43.6%
$206.78
+1.08 (+0.53%)
Pre-Market: $210.73 (+3.95, +1.91%)
Weekly Expected Move ±3.7%
$198
$206
$214
$222
$230
Credit Risk of going bust: lower than 57% of companies Debt: 24.7% of company value Bonds: $459.8M held by 158 funds, 99 bp over Treasuries → details ▾
If the stock fell to about $5.81 (down 97%), Jazz Pharmaceuticals plc would be worth roughly what it owes.
Total debt $4.41B against a stock market value of $13.42B.
Distance to default 5.85 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.68B (short-term plus half of long-term), stock volatility 36.3%; Altman Z'' 2.72. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Total debt $4.41B against a stock market value of $13.42B.
Distance to default 5.85 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.68B (short-term plus half of long-term), stock volatility 36.3%; Altman Z'' 2.72. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$5B
Revenue
+12.6% YoY
$941M
Net Income
+332.4% YoY
$2B
Free Cash Flow
+21.9% YoY
90.4%
Gross Margin
20.5%
Op. Margin
16.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE22.1%
ROA8.5%
ROIC26.4%
Valuation
P/E13.6
P/B2.7
EV/EBITDA12.7
Leverage
Debt/Equity0.92
Current Ratio1.78
Interest Cov.4.7x
Quality Scores
Piotroski F8/9
Altman Z2.62
Beneish M-2.61